After defining the three quickest paths to a cure, the grants were developed to help steer the research.
Began to fund in years 1-3 of the campaign -- 2007 through 2009 -- totaling $18 million
Innovative Basic Research
$400,000 per award for two years
Research in this area helps us understand what causes RA and helps develop novel treatments.
Translational Research
$400,000 per award for two years
Translational research is the direct study of patients and patient-derived materials to improve the understanding of RA. Research in this area studies the joints and its cells and tissues to develop methods to repair and replace damaged cartilage and bone.
Clinical Practice
$400,000 per award for two years
This area explores the issues that directly affect the clinical practice of rheumatology and patient access. This research can possibly lead to the development of methods to identify individuals at risk for RA in order to facilitate prevention and early treatment.
|
Began to fund in years 4 and 5 of the campaign -- 2010 through 2011 -- totaling $12 million
Novel Clinical Trials
$1.5 million per award for three years
Novel clinical trials help address the unmet needs in the development of new treatments for patients who may be resistant to conventional treatments or biologics.
Collaborative Projects
$1.2 million per award for three years
Collaborative projects involve large-scale collaborative research groups where expertise from multiple sites and investigators are joined together to solve one problem with comprehensive and innovative approaches.
|